Stock CSPCY CSPC PHARMACEUTICAL GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company CSPC Pharmaceutical Group Limited OTC Markets

Equities

CSPCY

US12591J2078

Pharmaceuticals

Delayed OTC Markets
Other stock markets
 20:59:26 28/06/2024 BST 		5-day change 1st Jan Change
3.11 USD -1.58% Intraday chart for CSPC Pharmaceutical Group Limited -1.89% -15.72%
06-28 CSPC Pharmaceutical Group Limited Announces Enlonstobart Injection Obtains Conditional Marketing Approval CI
06-28 CSPC Pharma's Breast Cancer Drug Gets Approval in China MT

Business Summary

CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:

- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);

- vitamin C (10.1%);

- antibiotics (6.2%);

- other (5%): including anhydrous and raw caffeine.

Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).

Number of employees: 23,500

Sales per Business

HKD in Million2022Weight2023Weight Delta
Finished Drugs
81.5 %
24,520 79.3 % 28,329 81.5 % +15.53%
Functional Food and Others
6.9 %
1,966 6.4 % 2,400 6.9 % +22.06%
Bulk Products - Vitamin C
6.1 %
2,529 8.2 % 2,132 6.1 % -15.70%
Bulk Products - Antibiotics
5.4 %
1,922 6.2 % 1,892 5.4 % -1.57%

Sales per region

HKD in Million2022Weight2023Weight Delta
China
86.4 %
26,139 84.5 % 30,038 86.4 % +14.91%
Other Asian Regions
5.0 %
1,736 5.6 % 1,749 5.0 % +0.77%
Europe
4.1 %
1,268 4.1 % 1,411 4.1 % +11.27%
North America
2.8 %
-- 974 2.8 % -
Others
1.7 %
284 0.9 % 580 1.7 % +104.23%

Managers

Managers TitleAgeSince
Cui Long Zhang CEO
 Chief Executive Officer 55 31/12/95
Dong Chen Cai CHM
 Chairman 70 31/12/97
Hao Jiang BRD
 Director/Board Member 41 31/07/20
Zhen Guo Wang BRD
 Director/Board Member 54 19/01/12
Huai Yu Wang BRD
 Director/Board Member 61 31/12/09
Wei Dong Pan BRD
 Director/Board Member 55 31/12/05
Jin Xu Wang PRN
 Corporate Officer/Principal 53 09/06/13
Tai On Lo SEC
 Corporate Secretary 69 31/12/20

Members of the board

Members of the board TitleAgeSince
Dong Chen Cai CHM
 Chairman 70 31/12/97
Huai Yu Wang BRD
 Director/Board Member 61 31/12/09
Cheuk Kin Law BRD
 Director/Board Member 61 07/03/21
Zhen Guo Wang BRD
 Director/Board Member 54 19/01/12
Chun Kwok Au BRD
 Director/Board Member 51 26/01/21
Jin Xu Wang PRN
 Corporate Officer/Principal 53 09/06/13
Chuan Chen BRD
 Director/Board Member 61 05/06/16
Chun Lei Li BRD
 Director/Board Member - 11/12/17
Quan Li BRD
 Director/Board Member 45 07/11/22
Hong Guang Wang BRD
 Director/Board Member 62 26/01/21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 11,896,091,732 8,344,572,069 ( 70.15 %) 0 70.15 %

Shareholders

NameEquities%Valuation
Dong Chen Cai
23.63 %
2,817,375,670 23.63 % 2 388 M $
Common Success International Ltd.
6.113 %
728,796,313 6.113 % 618 M $
UBS Asset Management (Hong Kong) Ltd.
2.952 %
351,929,752 2.952 % 298 M $
UBS Asset Management Switzerland AG
1.245 %
148,482,752 1.245 % 126 M $
BlackRock Fund Advisors
1.235 %
147,303,759 1.235 % 125 M $
GF Fund Management Co., Ltd.
0.9296 %
110,834,000 0.9296 % 94 M $
BlackRock Advisors (UK) Ltd.
0.9270 %
110,523,745 0.9270 % 94 M $
China Asset Management Co., Ltd.
0.5155 %
61,464,480 0.5155 % 52 M $
UBS Asset Management (UK) Ltd.
0.3982 %
47,472,470 0.3982 % 40 M $
Zhong Ou Asset Management Co., Ltd
0.3238 %
38,600,000 0.3238 % 33 M $
NameEquities%Valuation
RhumbLine Advisers LP
0.000875 %
26,068 0.000875 % 88 371 $
Operose Advisors LLC
0.000068 %
2,030 0.000068 % 6 882 $
PNC Investments LLC
0.000007 %
208 0.000007 % 705 $

Holdings

NameEquities%Valuation
CSPC INNOVATION PHARMACEUTICAL CO., LTD.
100.00%
 157,520,510 100.00% 681,052,527 $
WUHAN YZY BIOPHARMA CO., LTD.
46.32%
 51,241,785 46.32% 48,796,527 $

Company contact information

CSPC Pharmaceutical Group Ltd.

No. 226 Huanghe Street

050035, Shijiazhuang

+86 31 1870 37015

http://www.cspc.com.hk
address CSPC Pharmaceutical Group Limited(CSPCY)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for CSPC Pharmaceutical Group Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
6.22 HKD
Average target price
9.584 HKD
Spread / Average Target
+54.08%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+42.69% 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.48% 242B
ROCHE HOLDING AG Stock Roche Holding AG
+1.92% 224B
NOVARTIS AG Stock Novartis AG
+13.27% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 1093 Stock
  4. CSPCY Stock
  5. Company CSPC Pharmaceutical Group Limited